T. Rowe Price Associates’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$783K Buy
134,959
+25,414
+23% +$159K ﹤0.01% 2432
2026
Q1
$663K Buy
109,545
+24,853
+29% +$145K ﹤0.01% 2329
2025
Q4
$607K Buy
84,692
+22,710
+37% +$161K ﹤0.01% 2305
2025
Q3
$468K Buy
61,982
+503
+0.8% +$3.67K ﹤0.01% 2381
2025
Q2
$384K Buy
61,479
+2,620
+4% +$12.1K ﹤0.01% 2425
2025
Q1
$184K Buy
58,859
+5,634
+11% +$19.8K ﹤0.01% 2678
2024
Q4
$211K Buy
53,225
+10,748
+25% +$37.7K ﹤0.01% 2652
2024
Q3
$173K Buy
42,477
+693
+2% +$2.42K ﹤0.01% 2703
2024
Q2
$107K Buy
41,784
+8,971
+27% +$29.7K ﹤0.01% 2748
2024
Q1
$147K Buy
32,813
+5,062
+18% +$21.9K ﹤0.01% 2698
2023
Q4
$131K Buy
27,751
+2,398
+9% +$10.2K ﹤0.01% 2664
2023
Q3
$124K Buy
25,353
+2,520
+11% +$15.5K ﹤0.01% 2622
2023
Q2
$137K Buy
22,833
+6,401
+39% +$30.3K ﹤0.01% 2630
2023
Q1
$52K Buy
16,432
+2,204
+15% +$6.29K ﹤0.01% 2787
2022
Q4
$37K Buy
14,228
+62
+0.4% +$182 ﹤0.01% 2842
2022
Q3
$31K Buy
+14,166
New +$37K ﹤0.01% 2885

Other funds holding EVLV

T. Rowe Price Associates's EVLV Position: Q2 2026 in Review

T. Rowe Price Associates increased its Evolv Technologies (EVLV) stake by 23% in Q2 2026, buying an estimated $159K and bringing the position to 134,959 shares worth $783K. The position accounts for ﹤0.01% of the portfolio, ranked #2432.

T. Rowe Price Associates first reported a position in EVLV in Q3 2022 and has held it in 16 quarters since. 261 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • T. Rowe Price Associates held 134,959 shares of Evolv Technologies worth $783K as of Q2 2026.
  • T. Rowe Price Associates bought 25,414 Evolv Technologies shares in Q2 2026, an estimated $159K.
  • Evolv Technologies made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2432 holding.
  • T. Rowe Price Associates first reported a position in Evolv Technologies in Q3 2022 and has held it in 16 quarters since.
  • 261 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.